Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: Complex congenital cardiac lesions

Canadian Journal of Cardiology

Volumn 26, Issue 3, 2010, Pages

  Silversides, Candice K ^a   Salehian, Omid ^b   Oechslin, Erwin ^a   Schwerzmann, Markus ^c   Muhll, Isabelle Vonder ^d   Khairy, Paul ^e   Horlick, Eric ^a   Landzberg, Mike ^f   Meijboom, Folkert ^g   Warnes, Carole ^h   Therrien, Judith ⁱ  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF ALBERTA   (Canada)

^e MONTREAL HEART INSTITUTE   (Canada)

^f Boston Adult Congenital Heart (BACH)   (United States)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h MAYO CLINIC   (United States)

ⁱ MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Adult congenital heart disease; Complete transposition of the great arteries; Congenital heart disease; Congenitally corrected transposition of the great arteries; Cyanotic heart disease; Eisenmenger's syndrome; Fontan operation; Guidelines; Single ventricle

Indexed keywords

CANADA; CONGENITAL HEART DISEASE; CONSENSUS; CYANOSIS; CYANOTIC HEART DISEASE; DIFFERENTIAL DIAGNOSIS; EISENMENGER COMPLEX; FOLLOW UP; FONTAN PROCEDURE; GREAT VESSELS TRANSPOSITION; HEART ARRHYTHMIA; HEART FAILURE; HEART SINGLE VENTRICLE; HUMAN; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PULMONARY HYPERTENSION; REVIEW; SUDDEN DEATH; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 77950601990     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(10)70356-1     Document Type: Article

References (196)

1. Espinola-Zavaleta N, Alexanderson E, Attie F, et al. Right ventricular function and ventricular perfusion defects in adults with congenitally corrected transposition: Correlation of echocardiography and nuclear medicine. Cardiol Young 2004;14:174-181 (Pubitemid 43115345)
2. Massoudy P, Baltalarli A, de Leval MR, et al. Anatomic variability in coronary arterial distribution with regard to the arterial switch procedure. Circulation 2002;106:1980-1984 (Pubitemid 35176305)
3. Liebman J, Cullum L, Belloc NB. Natural history of transposition of the great arteries. Anatomy and birth and death characteristics. Circulation 1969;40:237-262
4. Mohsen AE, Rosenthal E, Qureshi SA, Tynan M. Stent implantation for superior vena cava occlusion after the Mustard operation. Catheter Cardiovasc Interv 2001;52:351-354 (Pubitemid 32184883)
5. MacLellan-Tobert SG, Cetta F, Hagler DJ. Use of intravascular stents for superior vena caval obstruction after the Mustard operation. Mayo Clin Proc 1996;71:1071-1076 (Pubitemid 126765459)
6. Wilson NJ, Clarkson PM, Barratt-Boyes BG, et al. Long-term outcome after the mustard repair for simple transposition of the great arteries. 28-year follow-up. J Am Coll Cardiol 1998;32:758-765
7. Lange R, Horer J, Kostolny M, et al. Presence of a ventricular septal defect and the Mustard operation are risk factors for late mortality after the atrial switch operation: Thirty years of follow-up in 417 patients at a single center. Circulation 2006;114:1905-1913 (Pubitemid 44665384)
8. Puley G, Siu S, Connelly M, et al. Arrhythmia and survival in patients >18 years of age after the Mustard procedure for complete transposition of the great arteries. Am J Cardiol 1999;83:1080-1084 (Pubitemid 29162795)
9. Benzaquen BS, Webb GD, Colman JM, Therrien J. Arterial switch operation after Mustard procedures in adult patients with transposition of the great arteries: Is it time to revise our strategy? Am Heart J 2004;147:E8.
10. Chang AC, Wernovsky G, Wessel DL, et al. Surgical management of late right ventricular failure after Mustard or Senning repair. Circulation 1992;86:II140-II149.
11. Horer J, Karl E, Theodoratou G, et al. Incidence and results of reoperations following the Senning operation: 27 years of follow-up in 314 patients at a single center. Eur J Cardiothorac Surg 2008;33:1061-1067
12. Bove T, De Meulder F, Vandenplas G, et al. Midterm assessment of the reconstructed arteries after the arterial switch operation. Ann Thorac Surg 2008;85:823-830 (Pubitemid 351253508)
13. Hutter PA, Bennink GB, Ay L, Raes IB, Hitchcock JF, Meijboom EJ. Influence of coronary anatomy and reimplantation on the long-term outcome of the arterial switch. Eur J Cardiothorac Surg 2000;18:207-213 (Pubitemid 30488819)
14. Hutter PA, Kreb DL, Mantel SF, Hitchcock JF, Meijboom EJ, Bennink GB. Twenty-five years' experience with the arterial switch operation. J Thorac Cardiovasc Surg 2002;124:790-797 (Pubitemid 36025358)
15. Bonhoeffer P, Bonnet D, Piechaud JF, et al. Coronary artery obstruction after the arterial switch operation for transposition of the great arteries in newborns. J Am Coll Cardiol 1997;29:202-206 (Pubitemid 27028740)
16. Losay J, Touchot A, Serraf A, et al. Late outcome after arterial switch operation for transposition of the great arteries. Circulation 2001;104:I121-I126.
17. Schwartz ML, Gauvreau K, del Nido P, Mayer JE, Colan SD. Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation. Circulation 2004;110:II128-II132. (Pubitemid 39263711)
18. Ciaravella JM Jr, McGoon DC, Danielson GK, Wallace RB, Mair DD, Ilstrup DM. Experience with the extracardiac conduit. J Thorac Cardiovasc Surg 1979;78:920-930
19. Kreutzer C, De Vive J, Oppido G, et al. Twenty-five-year experience with Rastelli repair for transposition of the great arteries. J Thorac Cardiovasc Surg 2000;120:211-223
20. Jenkins KJ, Newburger JW, Lock JE, Davis RB, Coffman GA, Iezzoni LI. In-hospital mortality for surgical repair of congenital heart defects: Preliminary observations of variation by hospital caseload. Pediatrics 1995;95:323-330
21. Stark J. Glenn Lecture. How to choose a cardiac surgeon. Circulation 1996;94:II1-II4.
22. Lester SJ, McElhinney DB, Viloria E, et al. Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. Am J Cardiol 2001;88:1314-1316 (Pubitemid 33132106)
23. Dore A, Houde C, Chan KL, et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: A multicenter, randomized, placebo-controlled clinical trial. Circulation 2005;112:2411-2416 (Pubitemid 41504490)
24. Robinson B, Heise CT, Moore JW, Anella J, Sokoloski M, Eshaghpour E. Afterload reduction therapy in patients following intraatrial baffle operation for transposition of the great arteries. Pediatr Cardiol 2002;23:618-623 (Pubitemid 36927826)
25. Doughan AR, McConnell ME, Book WM. Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol 2007;99:704-706 (Pubitemid 46273313)
26. Josephson CB, Howlett JG, Jackson SD, Finley J, Kells CM. A case series of systemic right ventricular dysfunction post atrial switch for simple D-transposition of the great arteries: The impact of betablockade. Can J Cardiol 2006;22:769-772 (Pubitemid 44227473)
27. Khairy P, Harris L, Landzberg MJ, et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: A multicenter study. Circ Arrhythm Electrophysiol 2008;1:250-257
28. Janousek J, Tomek V, Chaloupecky VA, et al. Cardiac resynchronization therapy: A novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol 2004;44:1927-1931 (Pubitemid 39424097)
29. Cowburn PJ, Parker JD, Cameron DA, Harris L. Cardiac resynchronization therapy: Retiming the failing right ventricle. J Cardiovasc Electrophysiol 2005;16:439-443 (Pubitemid 40504515)
30. Diller GP, Okonko D, Uebing A, Ho SY, Gatzoulis MA. Cardiac resynchronization therapy for adult congenital heart disease patients with a systemic right ventricle: Analysis of feasibility and review of early experience. Europace 2006;8:267-272 (Pubitemid 43905733)
31. Chow PC, Liang XC, Lam WW, Cheung EW, Wong KT, Cheung YF. Mechanical right ventricular dyssynchrony in patients after atrial switch operation for transposition of the great arteries. Am J Cardiol 2008;101:874-881
32. Poirier NC, Yu JH, Brizard CP, Mee RB. Long-term results of left ventricular reconditioning and anatomic correction for systemic right ventricular dysfunction after atrial switch procedures. J Thorac Cardiovasc Surg 2004;127:975-981
33. Cochrane AD, Karl TR, Mee RB. Staged conversion to arterial switch for late failure of the systemic right ventricle. Ann Thorac Surg 1993;56:854-861
34. Acar P, Sidi D, Bonnet D, Aggoun Y, Bonhoeffer P, Kachaner J. Maintaining tricuspid valve competence in double discordance: A challenge for the paediatric cardiologist. Heart 1998;80:479-483 (Pubitemid 28535536)
35. Winlaw DS, McGuirk SP, Balmer C, et al. Intention-to-treat analysis of pulmonary artery banding in conditions with a morphological right ventricle in the systemic circulation with a view to anatomic biventricular repair. Circulation 2005;111:405-411 (Pubitemid 40204423)
36. Lellan-Tobert SG, Cetta F, Hagler DJ. Use of intravascular stents for superior vena caval obstruction after the Mustard operation. Mayo Clin Proc 1996;71:1071-1076 (Pubitemid 126765459)
37. Khairy P, Landzberg MJ, Lambert J, O'Donnell CP. Long-term outcomes after the atrial switch for surgical correction of transposition: A meta-analysis comparing the Mustard and Senning procedures. Cardiol Young 2004;14:284-292
38. Legendre A, Losay J, Touchot-Kone A, et al. Coronary events after arterial switch operation for transposition of the great arteries. Circulation 2003;108(Suppl 1):II186-II190.
39. Horer J, Schreiber C, Dworak E, et al. Long-term results after the Rastelli repair for transposition of the great arteries. Ann Thorac Surg 2007;83:2169-2175
40. Gelatt M, Hamilton RM, McCrindle BW, et al. Arrhythmia and mortality after the Mustard procedure: A 30-year single-center experience. J Am Coll Cardiol 1997;29:194-201. (Pubitemid 27028739)
41. Gewillig M, Cullen S, Mertens B, Lesaffre E, Deanfield J. Risk factors for arrhythmia and death after Mustard operation for simple transposition of the great arteries. Circulation 1991;84:III187-III192.
42. Khairy P, Harris L, Landzberg MJ, et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: A multicenter study. Circ Arrhythm Electrophysiol 2008;1:250-257
43. Khairy P, Van Hare GF. Catheter ablation in transposition of the great arteries with Mustard or Senning baffles. Heart Rhythm 2009;6:283-289
44. Khairy P. EP challenges in adult congenital heart disease. Heart Rhythm 2008;5:1464-1472
45. Emmel M, Sreeram N, Brockmeier K, Bennink G. Superior vena cava stenting and transvenous pacemaker implantation (stent and pace) after the Mustard operation. Clin Res Cardiol 2007;96:17-22. (Pubitemid 46175366)
46. Triedman JK, Alexander ME, Love BA, et al. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol 2002;39:1827-1835
47. Collins KK, Love BA, Walsh EP, Saul JP, Epstein MR, Triedman JK. Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol 2000;86:969-974
48. Kanter RJ, Papagiannis J, Carboni MP, Ungerleider RM, Sanders WE, Wharton JM. Radiofrequency catheter ablation of supraventricular tachycardia substrates after Mustard and Senning operations for d-transposition of the great arteries. J Am Coll Cardiol 2000;35:428-441 (Pubitemid 30125535)
49. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: A literature review. J Am Coll Cardiol 2007;49:2303-2311 (Pubitemid 46891708)
50. Guedes A, Mercier LA, Leduc L, Berube L, Marcotte F, Dore A. Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. J Am Coll Cardiol 2004;44:433-437 (Pubitemid 38950607)
51. Canobbio MM, Morris CD, Graham TP, Landzberg MJ. Pregnancy outcomes after atrial repair for transposition of the great arteries. Am J Cardiol 2006;98:668-672
52. Genoni M, Jenni R, Hoerstrup SP, Vogt P, Turina M. Pregnancy after atrial repair for transposition of the great arteries. Heart 1999;81:276-277 (Pubitemid 29116340)
53. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-521 (Pubitemid 32738118)
54. Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation 2006;113:517-524 (Pubitemid 43754352)
55. Drenthen W, Pieper PG, Ploeg M, et al. Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur Heart J 2005;26:2588-2595 (Pubitemid 41677312)
56. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-1754
57. Samanek M, Voriskova M. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: A prospective Bohemia survival study. Pediatr Cardiol 1999;20:411-417
58. Pezard P, Banus Y, Laporte J, Geslin P, Garnier H, Tadei A. Corrected transposition of the great vessels in aged adults. Apropos of 2 patients aged 72 and 80. Arch Mal Coeur Vaiss 1986;79:1637-1642
59. Presbitero P, Somerville J, Rabajoli F, Stone S, Conte MR. Corrected transposition of the great arteries without associated defects in adult patients: Clinical profile and follow up. Br Heart J 1995;74:57-59
60. Connelly MS, Liu PP, Williams WG, Webb GD, Robertson P, McLaughlin PR. Congenitally corrected transposition of the great arteries in the adult: Functional status and complications. J Am Coll Cardiol 1996;27:1238-1243 (Pubitemid 26117719)
61. Graham TP Jr, Bernard YD, Mellen BG, et al. Long-term outcome in congenitally corrected transposition of the great arteries: A multi-institutional study. J Am Coll Cardiol 2000;36:255-261
62. Bharati S, McCue CM, Tingelstad JB, Mantakas M, Shiel F, Lev M. Lack of connection between the atria and the peripheral conduction system in a case of corrected transposition with congenital atrioventricular block. Am J Cardiol 1978;42:147-153 (Pubitemid 8387799)
63. Huhta JC, Maloney JD, Ritter DG, Ilstrup DM, Feldt RH. Complete atrioventricular block in patients with atrioventricular discordance. Circulation 1983;67:1374-1377 (Pubitemid 13105363)
64. van Son JA, Danielson GK, Huhta JC, et al. Late results of systemic atrioventricular valve replacement in corrected transposition. J Thorac Cardiovasc Surg 1995;109:642-652
65. Lundstrom U, Bull C, Wyse RK, Somerville J. The natural and "unnatural" history of congenitally corrected transposition. Am J Cardiol 1990;65:1222-1229 (Pubitemid 20160940)
66. Huhta JC, Maloney JD, Ritter DG, Ilstrup DM, Feldt RH. Complete atrioventricular block in patients with atrioventricular discordance. Circulation 1983;67:1374-1377 (Pubitemid 13105363)
67. Williams WG, Suri R, Shindo G, Freedom RM, Morch JE, Trusler GA. Repair of major intracardiac anomalies associated with atrioventricular discordance. Ann Thorac Surg 1981;31:527-531 (Pubitemid 11116758)
68. Westerman GR, Lang P, Castaneda AR, Norwood WI. Corrected transposition and repair of associated intracardiac defects. Circulation 1982;66:I197-I202.
69. Ilbawi MN, Ocampo CB, Allen BS, et al. Intermediate results of the anatomic repair for congenitally corrected transposition. Ann Thorac Surg 2002;73:594-599
70. Langley SM, Winlaw DS, Stumper O, et al. Midterm results after restoration of the morphologically left ventricle to the systemic circulation in patients with congenitally corrected transposition of the great arteries. J Thorac Cardiovasc Surg 2003;125:1229-1241 (Pubitemid 36759220)
71. Bove EL, Ohye RG, Devaney EJ, et al. Anatomic correction of congenitally corrected transposition and its close cousins. Cardiol Young 2006;16(Suppl 3):85-90.
72. Devaney EJ, Charpie JR, Ohye RG, Bove EL. Combined arterial switch and Senning operation for congenitally corrected transposition of the great arteries: Patient selection and intermediate results. J Thorac Cardiovasc Surg 2003;125:500-507
73. Chetaille P, Walsh EP, Triedman JK. Outcomes of radio-frequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm 2004;1:168-173 (Pubitemid 38878234)
74. Overgaard CB, Harrison DA, Siu SC, Williams WG, Webb GD, Harris L. Outcome of previous tricuspid valve operation and arrhythmias in adult patients with congenital heart disease. Ann Thorac Surg 1999;68:2158-2163 (Pubitemid 30027841)
75. Silka MJ, Rice MJ. Paradoxic embolism due to altered hemodynamic sequencing following transvenous pacing. Pacing Clin Electrophysiol 1991;14:499-503.
76. Khairy P, Landzberg MJ, Gatzoulis MA, et al. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: A multicenter study. Circulation 2006;113:2391-2397 (Pubitemid 43948046)
77. Therrien J, Barnes I, Somerville J. Outcome of pregnancy in patients with congenitally corrected transposition of the great arteries. Am J Cardiol 1999;84:820-824 (Pubitemid 29469793)
78. Connolly HM, Grogan M, Warnes CA. Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol 1999;33:1692-1695
79. Warnes CA. Transposition of the great arteries. Circulation 2006;114:2699-2709
80. Oski JA, Canter CE, Spray TL, Kan JS, Cameron DE, Murphy AM. Embolic stroke after ligation of the pulmonary artery in patients with functional single ventricle. Am Heart J 1996;132:836-840
81. Monagle P, Karl TR. Thromboembolic problems after the Fontan operation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2002;5:36-47.
82. Rosenthal DN, Friedman AH, Kleinman CS, Kopf GS, Rosenfeld LE, Hellenbrand WE. Thromboembolic complications after Fontan operations. Circulation 1995;92:II287-II293.
83. Bruns LA, Chrisant MK, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: An initial multicenter experience. J Pediatr 2001;138:505-511 (Pubitemid 32319723)
84. Ishibashi N, Park IS, Takahashi Y, et al. Effectiveness of carvedilol for congestive heart failure that developed long after modified Fontan operation. Pediatr Cardiol 2006;27:473-475 (Pubitemid 44222401)
85. Ringel RE, Peddy SB. Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease. Am J Cardiol 2003;91:1031-2, A9.
86. Seipelt RG, Franke A, Vazquez-Jimenez JF, et al. Thromboembolic complications after Fontan procedures: Comparison of different therapeutic approaches. Ann Thorac Surg 2002;74:556-562 (Pubitemid 34838867)
87. Cheung YF, Chay GW, Chiu CS, Cheng LC. Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure. Int J Cardiol 2005;102:509-513
88. Mahnke CB, Boyle GJ, Janosky JE, Siewers RD, Pigula FA. Anticoagulation and incidence of late cerebrovascular accidents following the Fontan procedure. Pediatr Cardiol 2005;26:56-61.
89. Piran S, Veldtman G, Siu S, Webb GD, Liu PP. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation 2002;105:1189-1194 (Pubitemid 34225819)
90. Inai K, Nakanishi T, Nakazawa M. Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan operation. Am Heart J 2005;150:588-594 (Pubitemid 41317635)
91. Kouatli AA, Garcia JA, Zellers TM, Weinstein EM, Mahony L. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation 1997;96:1507-1512 (Pubitemid 27375344)
92. Bendayan I, Casaldaliga J, Castello F, Miro L. Heparin therapy and reversal of protein-losing enteropathy in a case with congenital heart disease. Pediatr Cardiol 2000;21:267-268 (Pubitemid 30340877)
93. Donnelly JP, Rosenthal A, Castle VP, Holmes RD. Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation. J Pediatr 1997;130:474-478 (Pubitemid 27492697)
94. Bhagirath KM, Tam JW. Resolution of protein-losing enteropathy with low-molecular weight heparin in an adult patient with Fontan palliation. Ann Thorac Surg 2007;84:2110-2112
95. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Proteinlosing enteropathy after the Fontan operation: An international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998;115:1063-1073 (Pubitemid 28224401)
96. Therrien J, Webb GD, Gatzoulis MA. Reversal of protein losing enteropathy with prednisone in adults with modified fontan operations: Long term palliation or bridge to cardiac transplantation? Heart 1999;82:241-243
97. Kim SJ, Park IS, Song JY, Lee JY, Shim WS. Reversal of proteinlosing enteropathy with calcium replacement in a patient after Fontan operation. Ann Thorac Surg 2004;77:1456-1457
98. Rychik J. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis 2007;2:288-300.
99. Sugiyama H, Yoo SJ, Williams W, Benson LN. Characterization and treatment of systemic venous to pulmonary venous collaterals seen after the Fontan operation. Cardiol Young 2003;13:424-430 (Pubitemid 41630964)
100. Hosein RB, Clarke AJ, McGuirk SP, et al. Factors influencing early and late outcome following the Fontan procedure in the current era. The 'Two Commandments'? Eur J Cardiothorac Surg 2007;31:344-352
101. Giannico S, Hammad F, Amodeo A, et al. Clinical outcome of 193 extracardiac Fontan patients: The first 15 years. J Am Coll Cardiol 2006;47:2065-2073
102. Peters NS, Somerville J. Arrhythmias after the Fontan procedure. Br Heart J 1992;68:199-204.
103. Vargas FJ, Mayer JE Jr, Jonas RA, Castaneda AR. Atrioventricular valve repair or replacement in atriopulmonary anastomosis: Surgical considerations. Ann Thorac Surg 1987;43:403-405
104. Vitullo DA, DeLeon SY, Berry TE, et al. Clinical improvement after revision in Fontan patients. Ann Thorac Surg 1996;61:1797-1804
105. Fernandez G, Costa F, Fontan F, Naftel DC, Blackstone EH, Kirklin JW. Prevalence of reoperation for pathway obstruction after Fontan operation. Ann Thorac Surg 1989;48:654-659 (Pubitemid 19270435)
106. Bernstein D, Naftel D, Chin C, et al. Outcome of listing for cardiac transplantation for failed Fontan: A multi-institutional study. Circulation 2006;114:273-280 (Pubitemid 44297093)
107. Canter CE, Shaddy RE, Bernstein D, et al. Indications for heart transplantation in pediatric heart disease: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;115:658-676
108. Mavroudis C, Deal BJ, Backer CL, et al. J Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: Surgical lessons and outcomes. Ann Thorac Surg 2007;84:1457-1465
109. Rychik J, Rome JJ, Jacobs ML. Late surgical fenestration for complications after the Fontan operation. Circulation 1997;96:33-36 (Pubitemid 27298400)
110. Vyas H, Driscoll DJ, Cabalka AK, Cetta F, Hagler DJ. Results of transcatheter Fontan fenestration to treat protein losing enteropathy. Catheter Cardiovasc Interv 2007;69:584-589 (Pubitemid 46363863)
111. Marcelletti CF, Hanley FL, Mavroudis C, et al. Revision of previous Fontan connections to total extracardiac cavopulmonary anastomosis: A multicenter experience. J Thorac Cardiovasc Surg 2000;119:340-346 (Pubitemid 30091808)
112. Gamba A, Merlo M, Fiocchi R, et al. Heart transplantation in patients with previous Fontan operations. J Thorac Cardiovasc Surg 2004;127:555-562 (Pubitemid 38176663)
113. Stamm C, Friehs I, Mayer JE Jr, et al. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg 2001;121:28-41. (Pubitemid 32105320)
114. Kim SJ, Kim WH, Lim HG, Lee JY. Outcome of 200 patients after an extracardiac Fontan procedure. J Thorac Cardiovasc Surg 2008;136:108-116
115. Nakano T, Kado H, Tachibana T, et al. Excellent midterm outcome of extracardiac conduit total cavopulmonary connection: Results of 126 cases. Ann Thorac Surg 2007;84:1619-1625 (Pubitemid 47588125)
116. Mair DD, Puga FJ, Danielson GK. The Fontan procedure for tricuspid atresia: Early and late results of a 25-year experience with 216 patients. J Am Coll Cardiol 2001;37:933-939
117. Ono M, Boethig D, Goerler H, Lange M, Westhoff-Bleck M, Breymann T. Clinical outcome of patients 20 years after Fontan operation - effect of fenestration on late morbidity. Eur J Cardiothorac Surg 2006;30:923-929 (Pubitemid 44738628)
118. Khairy P, Fernandes SM, Mayer JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008;117:85-92. (Pubitemid 350291185)
119. Taylor DO, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth official adult heart transplant report - 2008. J Heart Lung Transplant 2008;27:943-956 (Pubitemid 47199081)
120. Gamba A, Merlo M, Fiocchi R, et al. Heart transplantation in patients with previous Fontan operations. J Thorac Cardiovasc Surg 2004;127:555-562 (Pubitemid 38176663)
121. Bernstein D, Naftel D, Chin C, et al. Outcome of listing for cardiac transplantation for failed Fontan: A multi-institutional study. Circulation 2006;114:273-280 (Pubitemid 44297093)
122. Jayakumar KA, Addonizio LJ, Kichuk-Chrisant MR, et al. Cardiac transplantation after the Fontan or Glenn procedure. J Am Coll Cardiol 2004;44:2065-2072
123. Weipert J, Noebauer C, Schreiber C, et al. Occurrence and management of atrial arrhythmia after long-term Fontan circulation. J Thorac Cardiovasc Surg 2004;127:457-464 (Pubitemid 38176651)
124. Weipert J, Noebauer C, Schreiber C, et al. Occurrence and management of atrial arrhythmia after long-term Fontan circulation. J Thorac Cardiovasc Surg 2004;127:457-464 (Pubitemid 38176651)
125. Mavroudis C, Deal BJ, Backer CL. The beneficial effects of total cavopulmonary conversion and arrhythmia surgery for the failed Fontan. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2002;5:12-24. (Pubitemid 38202147)
126. Mavroudis C, Backer CL, Deal BJ, Johnsrude C, Strasburger J. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg 2001;122:863-871 (Pubitemid 35462651)
127. Marcelletti CF, Hanley FL, Mavroudis C, et al. Revision of previous Fontan connections to total extracardiac cavopulmonary anastomosis: A multicenter experience. J Thorac Cardiovasc Surg 2000;119:340-346 (Pubitemid 30091808)
128. Cohen MI, Wernovsky G, Vetter VL, et al. Sinus node function after a systematically staged Fontan procedure. Circulation 1998;98:II352-II358. (Pubitemid 28512211)
129. Canobbio MM, Mair DD, van dV, Koos BJ. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996;28:763-767
130. Hoare JV, Radford D. Pregnancy after Fontan repair of complex congenital heart disease. Aust N Z J Obstet Gynaecol 2001;41:464-468 (Pubitemid 33100694)
131. Moodie DS, Ritter DG, Tajik AJ, O'Fallon WM. Long-term follow-up in the unoperated univentricular heart. Am J Cardiol 1984;53:1124-1128 (Pubitemid 14174263)
132. Ammash NM, Warnes CA. Survival into adulthood of patients with unoperated single ventricle. Am J Cardiol 1996;77:542-544
133. Knott-Craig CJ, Fryar-Dragg T, Overholt ED, Razook JD, Ward KE, Elkins RC. Modified hemi-Fontan operation: An alternative definitive palliation for high-risk patients. Ann Thorac Surg 1995;60:S554-S557.
134. Mainwaring RD, Lamberti JJ, Uzark K, Spicer RL, Cocalis MW, Moore JW. Effect of accessory pulmonary blood flow on survival after the bidirectional Glenn procedure. Circulation 1999;100:II151-II156. (Pubitemid 29523526)
135. Van Arsdell GS, Williams WG, Freedom RM. A practical approach to 1 1/2 ventricle repairs. Ann Thorac Surg 1998;66:678-680
136. Gatzoulis MA, Munk MD, Williams WG, Webb GD. Definitive palliation with cavopulmonary or aortopulmonary shunts for adults with single ventricle physiology. Heart 2000;83:51-57
137. Berdat PA, Belli E, Lacour-Gayet F, Planche C, Serraf A. Additional pulmonary blood flow has no adverse effect on outcome after bidirectional cavopulmonary anastomosis. Ann Thorac Surg 2005;79:29-36. (Pubitemid 40037433)
138. Caspi J, Pettitt TW, Ferguson TB Jr, Stopa AR, Sandhu SK. Effects of controlled antegrade pulmonary blood flow on cardiac function after bidirectional cavopulmonary anastomosis. Ann Thorac Surg 2003;76:1917-1921 (Pubitemid 37510505)
139. van de Wal HJ, Ouknine R, Tamisier D, Levy M, Vouhe PR, Leca F. Bi-directional cavopulmonary shunt: Is accessory pulsatile flow, good or bad? Eur J Cardiothorac Surg 1999;16:104-110 (Pubitemid 29376660)
140. Calvaruso DF, Rubino A, Ocello S, et al. Bidirectional Glenn and antegrade pulmonary blood flow: Temporary or definitive palliation? Ann Thorac Surg 2008;85:1389-1395
141. Burkhart HM, Dearani JA, Mair DD, et al. The modified Fontan procedure: Early and late results in 132 adult patients. J Thorac Cardiovasc Surg 2003;125:1252-1259
142. Veldtman GR, Nishimoto A, Siu S, et al. The Fontan procedure in adults. Heart 2001;86:330-335
143. Chowdhury UK, Airan B, Talwar S, et al. One and one-half ventricle repair: Results and concerns. Ann Thorac Surg 2005;80:2293-2300 (Pubitemid 41718075)
144. Van Arsdell GS, Williams WG, Maser CM, et al. Superior vena cava to pulmonary artery anastomosis: An adjunct to biventricular repair. J Thorac Cardiovasc Surg 1996;112:1143-1148
145. Delius RE, Rademecker MA, de Leval MR, Elliott MJ, Stark J. Is a high-risk biventricular repair always preferable to conversion to a single ventricle repair? J Thorac Cardiovasc Surg 1996;112:1561-1568
146. Lamour JM, Addonizio LJ, Galantowicz ME, et al. Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. Circulation 1999;100(19 Suppl):II200-II205.
147. Speziali G, Driscoll DJ, Danielson GK, et al. Cardiac transplantation for end-stage congenital heart defects: The Mayo Clinic experience. Mayo Cardiothoracic Transplant Team. Mayo Clin Proc 1998;73:923-928 (Pubitemid 28467690)
148. Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult lung and heart-lung transplantation report - 2007. J Heart Lung Transplant 2007;26:782-795 (Pubitemid 47199080)
149. Day RW, Etheridge SP, Veasy LG, et al. Single ventricle palliation: Greater risk of complications with the Fontan procedure than with the bidirectional Glenn procedure alone. Int J Cardiol 2006;106:201-210
150. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994;89:2673-2676 (Pubitemid 24322953)
151. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 1958;2:755-762
152. Engelfriet P, Boersma E, Oechslin E, et al. The spectrum of adult congenital heart disease in Europe: Morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005;26:2325-2333
153. Duffels MG, Engelfriet PM, Berger RM, et al. Pulmonary arterial hypertension in congenital heart disease: An epidemiologic perspective from a Dutch registry. Int J Cardiol 2007;120:198-204. (Pubitemid 47042253)
154. Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998;19:1845-1855
155. Cantor WJ, Harrison DA, Moussadji JS, et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol 1999;84:677-681
156. Diller GP, Dimopoulos K, Broberg CS, et al. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: A combined retrospective and case-control study. Eur Heart J 2006;27:1737-1742 (Pubitemid 44025362)
157. Saha A, Balakrishnan KG, Jaiswal PK, et al. Prognosis for patients with Eisenmenger syndrome of various aetiology. Int J Cardiol 1994;45:199-207. (Pubitemid 24227497)
158. Ghofrani HA, Wilkins MW, Rich S. Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension. Circulation 2008;118:1195-1201
159. Smadja DM, Gaussem P, Mauge L, et al. Circulating endothelial cells. A new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation 2009;119:374-381
160. Oechslin E. Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol 2004;97(Suppl 1):109-115 (Pubitemid 39601759)
161. Perloff JK, Child JS, Aboulhosn J. Cyanotic congenital heart disease: A multisystem disorder. Congenial heart disease in adults. Philadelphia: Elsevier, 2008:265-289
162. Vongpatanasin W, Brickner ME, Hillis LD, Lange RA. The Eisenmenger syndrome in adults. Ann Intern Med 1998;128:745-755
163. Perloff JK. Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism. Cardiol Clin 1993;11:689-699
164. Jones P, Patel A. Eisenmenger's syndrome and problems with anaesthesia. Br J Hosp Med 1995;54:214.
165. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007;115:1039-1050 (Pubitemid 46328298)
166. Dimopoulos K, Diller GP, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 2008;117:2320-2328 (Pubitemid 351681557)
167. Ammash NM, Connolly HM, Abel MD, Warnes CA. Noncardiac surgery in Eisenmenger syndrome. J Am Coll Cardiol 1999;33:222-227
168. Baum VC. The adult patient with congenital heart disease. J Cardiothorac Vasc Anesth 1996;10:261-282 (Pubitemid 26076520)
169. Harinck E, Hutter PA, Hoorntje TM, et al. Air travel and adults with cyanotic congenital heart disease. Circulation 1996;93:272-276 (Pubitemid 26031485)
170. Broberg CS, Uebing A, Cuomo L, Thein SL, Papadopoulos MG, Gatzoulis MA. Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. Heart 2007;93:1599-1603 (Pubitemid 350205558)
171. Silversides CK, Granton JT, Konen E, Hart MA, Webb GD, Therrien J. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 2003;42:1982-1987 (Pubitemid 37485576)
172. Niwa K, Perloff JK, Kaplan S, Child JS, Miner PD. Eisenmenger syndrome in adults: Ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol 1999;34:223-232
173. Broberg CS, Ujita M, Prasad S, et al. Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol 2007;50:634-642 (Pubitemid 47199004)
174. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:13S-24S. (Pubitemid 38450897)
175. Channick RN, Simonneau G, Sitbon O, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study. Lancet 2001;358:1119-1123 (Pubitemid 32971843)
176. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346:896-903. (Pubitemid 34984638)
177. Apostolopoulou SC, Manginas A, Cokkinos DV, Rammos S. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease. Heart 2005;91:1447-1452 (Pubitemid 41531824)
178. Schulze-Neick I, Gilbert N, Ewert R, et al. Adult patients with congenital heart disease and pulmonary arterial hypertension: First open prospective multicenter study of bosentan therapy. Am Heart J 2005;150:716. (Pubitemid 41396505)
179. Galie N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: A multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006;114:48-54. (Pubitemid 44305274)
180. Apostolopoulou SC, Manginas A, Cokkinos DV, Rammos S. Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: A 2-year study. Heart 2007;93:350-354 (Pubitemid 46579526)
181. Gatzoulis MA, Beghetti M, Galie N, et al. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: Results of the BREATHE-5 open-label extension study. Int J Cardiol 2008;127:27-32. (Pubitemid 351707527)
182. Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: Twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation 2005;111:3274-3280 (Pubitemid 40875000)
183. Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-2157 (Pubitemid 41653106)
184. Mukhopadhyay S, Sharma M, Ramakrishnan S, et al. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: A preliminary observational study. Circulation 2006;114:1807-1810 (Pubitemid 44673355)
185. Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 1999;99:1858-1865 (Pubitemid 29181415)
186. Fernandes SM, Newburger JW, Lang P, et al. Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology. Am J Cardiol 2003;91:632-635 (Pubitemid 36263277)
187. Perloff JK, Rosove MH, Child JS, Wright GB. Adults with cyanotic congenital heart disease: Hematologic management. Ann Intern Med 1988;109:406-413
188. Goerler H, Simon A, Gohrbandt B, et al. Heart-lung and lung transplantation in grown-up congenital heart disease: Long-term single centre experience. Eur J Cardiothorac Surg 2007;32:926-931 (Pubitemid 350081015)
189. Oechslin E, Jenni R. 40 years after the first atrial switch procedure in patients with transposition of the great arteries: Long-term results in Toronto and Zurich. Thorac Cardiovasc Surg 2000;48:233-237
190. Thorne SA, Barnes I, Cullinan P, Somerville J. Amiodarone-associated thyroid dysfunction: Risk factors in adults with congenital heart disease. Circulation 1999;100:149-154 (Pubitemid 29330013)
191. Oechslin E, Gatzoulis MA, Webb GD, Daubeney PEF. Eisenmenger's Syndrome. Diagnosis and Management of Adult Congenital Heart Disease. London: Churchill Livingstone, 2003:363-377
192. Weiss BM, Hess OM. Pulmonary vascular disease and pregnancy: Current controversies, management strategies, and perspectives. Eur Heart J 2000;21:104-115
193. Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 2009;30:256-265
194. Rosove MH, Perloff JK, Hocking WG, Child JS, Canobbio MM, Skorton DJ. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet 1986;2:313-315 (Pubitemid 16069615)
195. Perloff JK, Marelli AJ, Miner PD. Risk of stroke in adults with cyanotic congenital heart disease. Circulation 1993;87:1954-1959 (Pubitemid 23165639)
196. Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol 1996;28:768-772 (Pubitemid 26288663)